Format

Send to

Choose Destination
Pediatr Infect Dis J. 2014 Dec;33(12):1294-6. doi: 10.1097/INF.0000000000000431.

Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study.

Author information

1
From the *Baylor College of Medicine and Texas Children's Hospital, Houston, TX; †Children's Hospital of Orange County, Orange, CA; ‡Istituto Giannina Gaslini, Genova, Italy; §Monroe Carell Jr. Children's Hospital at Vanderbilt University, Nashville, TN; ¶Children's Hospital of Philadelphia, Philadelphia, PA; and ‖Duke University, Durham, NC.

Abstract

A multi-national prospective study of pediatric patients with invasive candidiasis between August 2007 and September 2012 was performed and included 441 infections. Variation in infecting Candida species and antifungals used was noted between US and non-US sites. Antifungal-associated adverse events were most common with polyene use.

PMID:
24892850
DOI:
10.1097/INF.0000000000000431
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center